Avoro Capital Advisors LLC

Holdings History for MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX)

Symbol: MLTX on Nasdaq
Investment type: Equity / Class A ordinary share, par value $0.0001 per share
Latest Disclosed Shares Owned: 2,000,000 shares
Security Ownership %: 3.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Avoro Capital Advisors LLC ownership in MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share (MLTX)

14 Nov 2025 - Avoro Capital Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,000,000 shares of MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share (MLTX). This represents 3.2% ownership of the company. In their previous filing dated 14 Aug 2025, Avoro Capital Advisors LLC had reported owning 4,150,000 shares, indicating a decrease of +52%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Avoro Capital Advisors LLC	3.2%	-48%	$14,340,000	2,000,000	-2,150,000	-52%	$7.17	13G/A	30 Sep 2025	14 Nov 2025, 09:03
Avoro Capital Advisors LLC	6.5%		$203,350,000	4,150,000			$49.00	13G	30 Jun 2025	14 Aug 2025, 06:57

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-0.19%	$0	0	-2,000,000	-100%	$18.77	Q4 2025
30 Sep 2025	0.19%	-0.2%	$14,340,000	2,000,000	-2,150,000	-52%	$7.17	Q3 2025
30 Jun 2025	3.4%	+1.1%	$195,880,000	4,150,000	+1,379,900	+50%	$47.20	Q2 2025
31 Mar 2025	1.7%	0%	$108,227,807	2,770,100	0		$39.07	Q1 2025
31 Dec 2024	2.1%	0%	$150,000,915	2,770,100	0		$54.15	Q4 2024
30 Sep 2024	2%	+0%	$139,668,442	2,770,100	+100	+0%	$50.42	Q3 2024
30 Jun 2024	1.6%	+0.1%	$121,796,900	2,770,000	+190,000	+7.4%	$43.97	Q2 2024
31 Mar 2024	1.5%	0%	$129,593,400	2,580,000	0		$50.23	Q1 2024
31 Dec 2023	2.2%	+0.48%	$155,806,200	2,580,000	+580,001	+29%	$60.39	Q4 2023
30 Sep 2023	1.8%	+0.24%	$113,999,943	1,999,999	+274,999	+16%	$57.00	Q3 2023
30 Jun 2023	1.2%	+1.2%	$87,975,000	1,725,000	+1,725,000	NEW	$51.00	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.